Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.
Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica.
Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis.
Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disability.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
Ontogeny and Functions of Central Nervous System Macrophages.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Acute disseminated encephalomyelitis after treatment of Plasmodium vivax malaria.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes-An orchestrated approach.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Acute Disseminated Encephalomyelitis Presenting with Hypertensive Emergency.
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Treatment of mood disorders in multiple sclerosis.
Pages
« first
‹ previous
…
496
497
498
499
500
501
502
503
504
…
next ›
last »